Efficacy and safety of bispecific antibodies in multiple myeloma patients with end-stage renal disease undergoing hemodialysis: a case report of elranatamab and a literature review. - Ogiya D; Suzuki R; Goto S; Nakagawa Y; Nasukawa M; Iwata S; Kawai H; Toyosaki M; Machida S; Onizuka M; Ogawa Y; Kawada H (Annals of hematology, 2025)